Effect of Sex Hormones on Experimental Autoimmune Uveoretinitis (EAU)

Immunological Investigations

Volumn 32, Issue 4, 2003, Pages 259-273

  Buggage, Ronald R ^a,b   Matteson, Dawn M ^a   Shen, De Fen ^a   Sun, Bing ^a   Tuaillon, Nadine ^a   Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b Bldg 10 ^*  (United States)

Author keywords

Estrogen; Experimental autoimmune uveoretinitis (EAU); Progesterone; Testosterone; Th1 Th2 cytokines

Indexed keywords

ANDROSTANOLONE; ANTIINFLAMMATORY AGENT; ESTRADIOL; ESTROGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; MESSENGER RNA; NORGESTREL; PROGESTERONE; RETINA S ANTIGEN; SEX HORMONE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFECT; FEMALE; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL; UVEORETINITIS;

EID: 0242286582     PISSN: 08820139     EISSN: None     Source Type: Journal    
DOI: 10.1081/IMM-120025105     Document Type: Article

References (33)

1. Abbas, A. K., Murphy, K. M. (1996). Functional diversity of helper T lymphocytes. Nature 383(6603):787-793.
2. Agarwal, R. K., Chan, C. C. (1999). Pregnancy ameliorates induction and expression of experimental autoimmune uveitis. J. Immunol. 162(5):2648-2654.
3. Ahmed, S. A., Penhale, W. J. (1985). Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am. J. Pathol. 121 (3):531-551.
4. Bao, M., Yang, Y. (2002). Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 168(10):5369-5375.
5. Caspi, R. R. (1999). Immune mechanisms in uveitis. Springer Semin. Immunopathol. 21 (2):113-124.
6. Caspi, R. R., Roberge, F. G. (1986). T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J. Immunol. 136(3):928-933.
7. Caspi, R. R., Sun, B. (1997). T cell mechanisms in experimental autoimmune uveoretinitis: susceptibility is a function of the cytokine response profile. Eye 11 (Pt. 2):209-212.
8. Chavis, P. S., Tabbara, K. F. (2000). Effects of pregnancy on the course of uveitis. In: Dodds, E. M., Couto, C. A., eds. Uveitis in the Third Millennium. Elsevier Science: New York, pp. 167-170.
9. Chrousos, G. P. (1995). The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332(20):1351-1362.
10. Cutolo, M. (2000). Sex hormone adjuvant therapy in rheumatoid arthritis. Rheum. Dis. Clin. North Am. 26(4):881-895.
11. Cutolo, M., Sulli, A. (1995). Estrogens, the immune response and autoimmunity. Clin. Exp. Rheumatol. 13(2):217-226.
12. Dalal, M., Kim, S. (1997). Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J. Immunol. 159(1):3-6.
13. Fox, H. S. (1995). Sex steroids and the immune system. Ciba Found. Symp. 191:203-211.
14. Ito, A., Bebo, B. F. Jr. (2001). Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J. Immunol. 167(1):542-552.
15. Jansson, L., Holmdahl, R. (1998). Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm. Res. 47(7):290-301.
16. Kotake, S., de Smet, M. D. (1991). Analysis of the pivotal residues of the immunodominant and highly uveitogenic determinant of interphotoreceptor retinoid-binding protein. J. Immunol. 146(9):2995-3001.
17. Lahita, R. G. (1997). Predisposing factors to autoimmune disease. Int. J. Fertil. Womens Med. 42(2):115-119.
18. Lahita, R. G. (1999). The role of sex hormones in systemic lupus erythematosus. Curr. Opin. Rheumatol. 11(5):352-356.
19. Lillehoj, H. S., Beisel, K. (1981). Genetic factors controlling the susceptibility to experimental autoimmune thyroiditis in inbred rat strains. J. Immunol. 127(2):654-659.
20. Liva, S. M., Voskuhl, R. R. (2001). Testosterone acts directly on CD4(+) T lymphocytes to increase IL-10 production. J. Immunol. 167(4):2060-2067.
21. Merrill, P. T., Kim, J. (1997). Uveitis in the southeastern United States. Curr. Eye Res. 16(9):865-874.
22. Nussenblatt, R. B., Dinning, W. J. (1985). Local cyclosporine therapy for experimental autoimmune uveitis in rats. Arch. Ophthalmol. 103(10):1559-1562.
23. Offner, H., Zamora, A. (2002). A synthetic androstene derivative and a natural androstene metabolite inhibit relapsing-remitting EAE. J. Neuroimmunol. 130(1-2):128-139.
24. Redmond, T. M., Sanui, H. (1989). Immune responses to peptides derived from the retinal protein IRBP: immunopathogenic determinants are not necessarily immunodominant. Clin. Immunol. Immunopathol. 53(2 Pt. 1):212-224.
25. Rizzo, L. V., Silver, P. (1996). Establishment and characterization of a murine CD4 + T cell line and clone that induce experimental autoimmune uveoretinitis in B10.A mice. J. Immunol. 156(4):1654-1660.
26. Roberge, F. G., Lorberboum-Galski, H. (1989). Selective immunosuppression of activated T cells with the chimeric toxin IL-2-PE40. Inhibition of experimental autoimmune uveoretinitis. J. Immunol. 143(11):3498-3502.
27. Sanui, H., Redmond, T. M. (1989). Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphotoreceptor retinoid-binding protein (IRBP). J. Exp. Med. 169(6):1947-1960.
28. Sun, B., Wells, J. (1996). A simplified, competitive RT-PCR method for measuring rat IFN-gamma mRNA expression. J. Immunol. Methods 195(1-2):139-148.
29. Sun, B., Sun, S. H. (2000). Evaluation of in vivo cytokine expression in EAU-susceptible and resistant rats: a role for IL-10 in resistance? Exp. Eye Res. 70(4):493-502.
30. Van Vollenhoven, R. F., McGuire, J. L. (1994). Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases? Clevel. Clin. J. Med. 61(4):276-284.
31. Van Vollenhoven, R., Morabito, L. M. (1998). Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patietns treated up to 12 months. J. Rheumatol. 25(2):285-289.
32. Wilder, R. L. (1996). Hormones and autoimmunity: animal models of arthritis. Baillieres Clin. Rheumatol. 10(2):259-271.
33. Wilder, R. L. (2002). Neuroimmunoendocrinology of the rheumatic diseases: past, present, and future. Ann. N. Y. Acad. Sci. 966:13-19.